DGAP-Adhoc: OPDENERGY HOLDING, S A : CNMV approves the prospectus for the initial offering of ordinary shares of Opdenergy boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.
Lucara First Quarter 2021 Results To Be Released Thursday, May 6, 2021
VANCOUVER, BC, April 22, 2021 /PRNewswire/ (TSX: LUC) (BSE: LUC) (Nasdaq Stockholm: LUC) Lucara Diamond Corp. ( Lucara or the Company ) announces that it will be publishing its 2021 First Quarter Results on Thursday, May 6, 2021 after market close in North America. View PDF version.
The Company will host a conference call and webcast to discuss the results on Friday, May 7, 2021 at 7:00 a.m. Pacific, 10:00 a.m. Eastern, 3:00 p.m. UK, 4:00 p.m. CET.
CONFERENCE CALL:
Please call in 10 minutes before the conference call starts and stay on the line (an operator will be available to assist you).
Share:
CLEVELAND, April 21, 2021 (GLOBE NEWSWIRE) Lincoln Electric Holdings, Inc., (NASDAQ:LECO) announced today that its Board of Directors has declared a quarterly cash dividend of $0.51 per common share, payable July 15, 2021 to shareholders of record as of June 30, 2021.
Business
Lincoln Electric is the world leader in the design, development and manufacture of arc welding products, automated joining, assembly and cutting systems, plasma and oxy-fuel cutting equipment and has a leading global position in brazing and soldering alloys. Headquartered in Cleveland, Ohio, Lincoln has 55 manufacturing locations in 18 countries and a worldwide network of distributors and sales offices covering more than 160 countries. For more information about Lincoln Electric and its products and services, visit the Company s website at https://www.lincolnelectric.com.
Prothena Presents Phase 1 Study Results of PRX004 in Oral Presentation at AAN 2021
Slowing of neuropathy progression for all 7 evaluable patients, evidenced by a +1.29 point mean change in NIS, was more favorable than expected progression of +9.2 points
Improvement in neuropathy for 3 of these 7 evaluable patients demonstrated by a mean change in NIS of -3.33 points
Improvement in cardiac function for all 7 evaluable patients demonstrated by a decrease in global longitudinal strain (GLS)
Emerging Science Oral Presentation today at AAN 2021
DUBLIN, Ireland, April 18, 2021 (GLOBE NEWSWIRE) Prothena Corporation plc (NASDAQ:PRTA) today presented positive results from the Phase 1 study of PRX004 as part of the Emerging Science Session at the American Academy of Neurology (AAN) 2021 Virtual Annual Meeting. PRX004 showed favorable results as demonstrated by slowing of neuropathy progression for all 7 evaluable patients at 9 months, including improvement in neuropathy in 3 of the